Answers are grounded in this paper and cite their sources.
Prospective intra-individual study reveals lower stenosis severity but greater disease extent on photon-counting CT, highlighting implications for risk classification.
BACKGROUND: Quantitative coronary stenosis and plaque volumes have demonstrated intra-individual differences between ultrahigh-resolution (UHR) photon-counting detector (PCD)-CT and energy-integrating detector (EID)-CT. This study aimed to assess the impact of UHR PCD-CT on semiquantitative scores of coronary artery disease (CAD) burden compared with EID-CT. METHODS: Patients undergoing coronary CT angiography (CCTA) on an EID-CT system for stable chest pain or pre-transcatheter aortic valve replacement evaluation were prospectively enrolled for UHR PCD-CT scan within 30 days. Both datasets were visually evaluated using five established semiquantitative scores: Segment Involvement Score (SIS), Segment Stenosis Score (SSS), Multivessel Aggregate Stenosis Score (MVAS), CCTA-adapted Leaman score (CT-LeSc), and Coronary Artery Disease Reporting and Data System (CAD-RADS). Additionally, the total number of detected plaques and high-risk features were reported (positive remodeling, spotty calcification, low-attenuation, and napkin-ring sign). RESULTS: The cohort comprised 46 patients (37 men, 68.4 ± 6.9 years). When assessing stenosis severity, PCD-CT showed lower SSS (3.5 [1.3-5.0] vs 6.5 [3.0-9.8], p < 0.001), MVAS (5.5 [4.0-7.0] vs 7.0 [5.0-9.0], p < 0.001), and CT-LeSc (10.4 [8.5-13.9] vs 11.2 [8.8-15.4], p = 0.032). Furthermore, 52 % (24/46) of patients were reclassified to a lower CAD-RADS category compared to EID-CT. In terms of CAD extent, PCD-CT demonstrated higher SIS (8.0 [6.0-9.0] vs 7.0 [6.0-8.8], p = 0.018) and plaque count (9.0 [7.0-13.8] vs 7.0 [7.0-9.8] p < 0.001). Positive remodeling was less frequent in PCD-CT datasets (2.0 [1.0-4.3] vs 1.0 [0.0-3.0], p = 0.012), with no significant differences in other high-risk features. CONCLUSION: The use of UHR PCD-CT detects less severe, but more extensive CAD compared to EID-CT. The effect of such CCTA-based differences on individual risk stratification needs further investigation.
No takes yet. Share an insight, caveat, or question.
Tremamunno et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: